Company news
ValiRx PLC news in 2023
ValiRx PLC's news releases, calls and decks from 2023, newest first.
Result of Retail Offer, Subscription
December 19, 2023
Posting of Circular, Notice of GM and Ops Review
December 15, 2023
Retail Offer
December 13, 2023
Conditional Fundraise, Notice of General Meeting
December 13, 2023
ValiRx strikes deal with Ambrose Healthcare to license late-stage cancer treatment
December 6, 2023
Agreement to License VAL401 to Ambrose Healthcare
December 5, 2023
Evaluation Agreement with StingRay Bio
November 10, 2023
Statement re Share Price Movement
October 6, 2023
Operational Review
September 28, 2023
Collaborative Services Agreement
August 14, 2023
Inaphaea BioLabs secures first external contract
July 19, 2023
Virtual AGM Access
June 20, 2023
Inaphaea BioLabs Operational Update
June 19, 2023
Conclusion of Hokkaido Evaluation Agreement
June 16, 2023
Asset Purchase – Imagen Therapeutics
June 14, 2023
Expanded agreement with University of Barcelona
June 7, 2023
Notice of Results and Investor Webinar
May 26, 2023
Quarterly Operational Update
March 31, 2023
Incorporation of Inaphaea BioLabs Limited
March 1, 2023
Second Price Monitoring Extn
February 24, 2023
Price Monitoring Extension
February 24, 2023
Operational Update
January 31, 2023
Broker Offer Results
January 17, 2023
Launch of Broker Offer
January 13, 2023
Issue of Equity & Proposed Broker Offer
January 13, 2023